Latest filing published 03 Mar 2022 for MEDNAX, INC., €214k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Roger Mack Hinson: trading record in brief
Roger Mack Hinson (chief executive) discloses dealings in Pediatrix Medical Group, Inc. to SEC (Form 4). The record holds 6 filings, for trades running from 1 March 2021 to 1 March 2022.
On the market, this insider has only sold: 2 sales, €458k in total. Besides market trades, the filings include 4 share grants.
The record was last updated on 3 March 2022 with a share grant (€214k) in Pediatrix Medical Group, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Roger Mack Hinson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,244 shares@ US$23.4731.9% of flowCommon StockSEC:0001209191-22-015591:0
- 8,800 shares@ US$28.3832.0% of flowCommon StockSEC:0001209191-21-063836:0
- 8,799 shares@ US$32.3536.1% of flowCommon StockSEC:0001209191-21-050907:0
3 of 3 declarations
